Qi Kang

Ambivert

[Dept. of Family Medicine and Primary Care, HKU @HKU_FMPC]

[Beyond the Office Visit: The Future of Primary Care]

On August 13th, Harvard Associate Professor, Dr. Ishani Ganguli (@IshaniG ), visited our department to share her insights and research on primary care in the United States. She presented the recent trends and barriers to primary care visits, as well as discussed ways to improve the quality and use of primary care among patients. In particular, Dr. Ganguli highlighted the benefits of practical innovations, such as adopting online appointment systems and telemedicine, as a means of improving primary care access both in the United States and beyond.

Thank you, Dr. Ganguli for sharing such a thoughtful presentation!

#HKUFMPC #FamilyMedicine #HKUMed #PrimaryCare

[Dept. of Family Medicine and Primary Care, HKU @HKU_FMPC]

🎉Congratulations to Mr. Ramon Shuochi WEI, https://t.co/RKWU647NTt (Year 4 Ph.D. candidate, supervised by Prof. William Wong) for receiving the YS and Christabel Lung Postgraduate Scholarship for the academic year 2025/26!

🎓 About the scholarship:
The "Y S and Christabel Lung Fund" was then set up as a perpetual endowment to support scholarships in the Faculty of Engineering and the Li Ka Shing Faculty of Medicine. The scholarship shall be awarded to the research postgraduate students with outstanding academic performance and research achievements.

👏This honor recognizes Ramon's academic excellence and sustained dedication to interdisciplinary research.

#HKU #HKUMed #HKUFMPC #ResearchExcellence #ScholarshipAward

[Franco WT Cheng @kfranco_c]

How often do patients stay on GAS without clear indications? It happens naturally in complex care, inspiring my new @KIReports paper. We found GAS initiation links to higher peritonitis & mortality risks in PD. https://t.co/TtiqlpanML

[Eric YF Wan @EricWan_HKU]

Our @Age_and_Ageing paper found that lowering BP of <130/80 mmHg in old and very old patients was associated with better #cardiovascular and #mortality outcomes without increased adverse events, suggesting a lower BP target may be safe for older patients.
https://t.co/6apws5xE5o

[Eric YF Wan @EricWan_HKU]

Our target trial emulation analysis on @NatureComms provides evidence for a BP target of <130/80 mmHg in clinical guidelines for the treatment of adult HT patients in primary care, with a lower risk of HT-related #complications and all-cause #mortality.

https://t.co/FKdSn7pcnx

[Eric YF Wan @EricWan_HKU]

Our interrupted time series analysis on @JournalofNeph illustrates the indirect effect of the #COVID-19 on Chronic Kidney Disease #CKD patients in Hong Kong, as delayed #CVD diagnoses and increased #mortality rate were seen among non-COVID CKD patients.

https://t.co/MH9zY1jGdo

[Eric YF Wan @EricWan_HKU]

Our @amjmed paper confirms the substantial economic burden of smoking to Hong Kong despite its low #smoking prevalence. Healthcare costs for women and middle-aged smokers are disproportionately higher, and targeted #cessation programs can be a solution.

https://t.co/qMEPhV6nLu

[Eric YF Wan @EricWan_HKU]

Our paper on @BMCMedicine provides an updated and comprehensive estimate of the #mortality and #morbidity burden associated with #smoking, using a 1.6 million cohort in Hong Kong.
https://t.co/iAeRe8lROj

[Eric YF Wan @EricWan_HKU]

From #HongKong #Chronic Disease Co-Care Pilot Scheme #CDCC participants, our team found that #smoking, physical inactivity, and lower educational level were significant associated factors for #preDM, Type 2 #diabetes #T2DM, and #hypertension #HT. https://t.co/yYtlycaAaP

[Eric YF Wan @EricWan_HKU]

In our #multinational study in @JInternMed, #statin initiation may be associated with increased risk of incident #MyastheniaGravis #MG during the first 6–12 months, with a greater magnitude of risk elevation for higher intensity of statin therapy.
https://t.co/V0t7QlR9a7

[Eric YF Wan @EricWan_HKU]

We found in the early phase of the #Chronic Disease Co-Care #CDCC Pilot Scheme, #glycemic, #bloodpressure, #lipid, and #BMI indicators improved among #PreDM, #T2DM and #HT patients, with particularly pronounced effects in males and those younger than 65.
https://t.co/u0VbK0cHAa

[Eric YF Wan @EricWan_HKU]

Our publication at Chinese Journal of General Practitioners introduces #HongKong #Chronic Disease Co-Care Pilot Scheme #CDCC, which can achieve better health outcomes by early #screening and #intervention while lowering overall medical #expenditure.
https://t.co/qEp2b0tFa0

[Yin Zhang @zhangyin0904]

Happy to share our study on global Clostridioides difficile infection treatment trends in International Journal of Antimicrobial Agents. Use of fidaxomicin and oral vancomycin is rising globally, but access remains unequal across regions and incomes.
🔗 https://t.co/eKc7XdUTTq

[Eric YF Wan @EricWan_HKU]

The team:
@VincentKCYan
@BlaisJoseph
Dr. JM Gamble of University of Waterloo
@Esther_CSMPRHKU
@Prof_IanWong

@hkumed
@UWPharmacy
@HKU_FMPC
@HkuPharm
@CSMPR_HKUPharm
#HKU #HKUMed #FMPC #PrimaryCare #HKUPharm #CSMPR #DM #diabetes #TargetTrialEmulation

[Eric YF Wan @EricWan_HKU]

https://t.co/hOYx6cW2jx

[Eric YF Wan @EricWan_HKU]

https://t.co/w62D1emMeD

[Eric YF Wan @EricWan_HKU]

https://t.co/h5nyCBZ6PO

[Eric YF Wan @EricWan_HKU]

https://t.co/ioC67BAAKr

[Eric YF Wan @EricWan_HKU]

https://t.co/0YQeHVAsOk

[Annals of Int Med @AnnalsofIM]

ICYMI: The findings of a large cohort study suggest that #statins may have broader protective value in adults with type 2 #diabetes than previously assumed. Read now: https://t.co/i4akHwjKeg